Cargando…

Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study

Individuals with the three base pair deletion NM_000267.3(NF1):c.2970_2972del p.(Met992del) have been recognised to present with a milder neurofibromatosis type 1 (NF1) phenotype characterised by café-au-lait macules (CALs) and intertriginous freckling, as well as a lack of cutaneous, subcutaneous a...

Descripción completa

Detalles Bibliográficos
Autores principales: Forde, Claire, Burkitt-Wright, Emma, Turnpenny, Peter D., Haan, Eric, Ealing, John, Mansour, Sahar, Holder, Muriel, Lahiri, Nayana, Dixit, Abhijit, Procter, Annie, Pacot, Laurence, Vidaud, Dominique, Capri, Yline, Gerard, Marion, Dollfus, Hélène, Schaefer, Elise, Quelin, Chloé, Sigaudy, Sabine, Busa, Tiffany, Vera, Gabriella, Damaj, Lena, Messiaen, Ludwine, Stevenson, David A., Davies, Peter, Palmer-Smith, Sheila, Callaway, Alison, Wolkenstein, Pierre, Pasmant, Eric, Upadhyaya, Meena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904810/
https://www.ncbi.nlm.nih.gov/pubmed/34897289
http://dx.doi.org/10.1038/s41431-021-01015-4
_version_ 1784665027951722496
author Forde, Claire
Burkitt-Wright, Emma
Turnpenny, Peter D.
Haan, Eric
Ealing, John
Mansour, Sahar
Holder, Muriel
Lahiri, Nayana
Dixit, Abhijit
Procter, Annie
Pacot, Laurence
Vidaud, Dominique
Capri, Yline
Gerard, Marion
Dollfus, Hélène
Schaefer, Elise
Quelin, Chloé
Sigaudy, Sabine
Busa, Tiffany
Vera, Gabriella
Damaj, Lena
Messiaen, Ludwine
Stevenson, David A.
Davies, Peter
Palmer-Smith, Sheila
Callaway, Alison
Wolkenstein, Pierre
Pasmant, Eric
Upadhyaya, Meena
author_facet Forde, Claire
Burkitt-Wright, Emma
Turnpenny, Peter D.
Haan, Eric
Ealing, John
Mansour, Sahar
Holder, Muriel
Lahiri, Nayana
Dixit, Abhijit
Procter, Annie
Pacot, Laurence
Vidaud, Dominique
Capri, Yline
Gerard, Marion
Dollfus, Hélène
Schaefer, Elise
Quelin, Chloé
Sigaudy, Sabine
Busa, Tiffany
Vera, Gabriella
Damaj, Lena
Messiaen, Ludwine
Stevenson, David A.
Davies, Peter
Palmer-Smith, Sheila
Callaway, Alison
Wolkenstein, Pierre
Pasmant, Eric
Upadhyaya, Meena
author_sort Forde, Claire
collection PubMed
description Individuals with the three base pair deletion NM_000267.3(NF1):c.2970_2972del p.(Met992del) have been recognised to present with a milder neurofibromatosis type 1 (NF1) phenotype characterised by café-au-lait macules (CALs) and intertriginous freckling, as well as a lack of cutaneous, subcutaneous and plexiform neurofibromas and other NF1-associated complications. Examining large cohorts of patients over time with this specific genotype is important to confirm the presentation and associated risks of this variant across the lifespan. Forty-one individuals with the in-frame NF1 deletion p.Met992del were identified from 31 families. Clinicians completed a standardised clinical questionnaire for each patient and the resulting data were collated and compared to published cohorts. Thirteen patients have been previously reported, and updated clinical information has been obtained for these individuals. Both CALs and intertriginous freckling were present in the majority of individuals (26/41, 63%) and the only confirmed features in 11 (27%). 34/41 (83%) of the cohort met NIH diagnostic criteria. There was a notable absence of all NF1-associated tumour types (neurofibroma and glioma). Neurofibroma were observed in only one individual—a subcutaneous lesion (confirmed histologically). Nineteen individuals were described as having a learning disability (46%). This study confirms that individuals with p.Met992del display a mild tumoural phenotype compared to those with ‘classical’, clinically diagnosed NF1, and this appears to be the case longitudinally through time as well as at presentation. Learning difficulties, however, appear to affect a significant proportion of NF1 subjects with this phenotype. Knowledge of this genotype–phenotype association is fundamental to accurate prognostication for families and caregivers.
format Online
Article
Text
id pubmed-8904810
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer International Publishing
record_format MEDLINE/PubMed
spelling pubmed-89048102022-03-23 Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study Forde, Claire Burkitt-Wright, Emma Turnpenny, Peter D. Haan, Eric Ealing, John Mansour, Sahar Holder, Muriel Lahiri, Nayana Dixit, Abhijit Procter, Annie Pacot, Laurence Vidaud, Dominique Capri, Yline Gerard, Marion Dollfus, Hélène Schaefer, Elise Quelin, Chloé Sigaudy, Sabine Busa, Tiffany Vera, Gabriella Damaj, Lena Messiaen, Ludwine Stevenson, David A. Davies, Peter Palmer-Smith, Sheila Callaway, Alison Wolkenstein, Pierre Pasmant, Eric Upadhyaya, Meena Eur J Hum Genet Article Individuals with the three base pair deletion NM_000267.3(NF1):c.2970_2972del p.(Met992del) have been recognised to present with a milder neurofibromatosis type 1 (NF1) phenotype characterised by café-au-lait macules (CALs) and intertriginous freckling, as well as a lack of cutaneous, subcutaneous and plexiform neurofibromas and other NF1-associated complications. Examining large cohorts of patients over time with this specific genotype is important to confirm the presentation and associated risks of this variant across the lifespan. Forty-one individuals with the in-frame NF1 deletion p.Met992del were identified from 31 families. Clinicians completed a standardised clinical questionnaire for each patient and the resulting data were collated and compared to published cohorts. Thirteen patients have been previously reported, and updated clinical information has been obtained for these individuals. Both CALs and intertriginous freckling were present in the majority of individuals (26/41, 63%) and the only confirmed features in 11 (27%). 34/41 (83%) of the cohort met NIH diagnostic criteria. There was a notable absence of all NF1-associated tumour types (neurofibroma and glioma). Neurofibroma were observed in only one individual—a subcutaneous lesion (confirmed histologically). Nineteen individuals were described as having a learning disability (46%). This study confirms that individuals with p.Met992del display a mild tumoural phenotype compared to those with ‘classical’, clinically diagnosed NF1, and this appears to be the case longitudinally through time as well as at presentation. Learning difficulties, however, appear to affect a significant proportion of NF1 subjects with this phenotype. Knowledge of this genotype–phenotype association is fundamental to accurate prognostication for families and caregivers. Springer International Publishing 2021-12-13 2022-03 /pmc/articles/PMC8904810/ /pubmed/34897289 http://dx.doi.org/10.1038/s41431-021-01015-4 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Article
Forde, Claire
Burkitt-Wright, Emma
Turnpenny, Peter D.
Haan, Eric
Ealing, John
Mansour, Sahar
Holder, Muriel
Lahiri, Nayana
Dixit, Abhijit
Procter, Annie
Pacot, Laurence
Vidaud, Dominique
Capri, Yline
Gerard, Marion
Dollfus, Hélène
Schaefer, Elise
Quelin, Chloé
Sigaudy, Sabine
Busa, Tiffany
Vera, Gabriella
Damaj, Lena
Messiaen, Ludwine
Stevenson, David A.
Davies, Peter
Palmer-Smith, Sheila
Callaway, Alison
Wolkenstein, Pierre
Pasmant, Eric
Upadhyaya, Meena
Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title_full Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title_fullStr Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title_full_unstemmed Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title_short Natural history of NF1 c.2970_2972del p.(Met992del): confirmation of a low risk of complications in a longitudinal study
title_sort natural history of nf1 c.2970_2972del p.(met992del): confirmation of a low risk of complications in a longitudinal study
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8904810/
https://www.ncbi.nlm.nih.gov/pubmed/34897289
http://dx.doi.org/10.1038/s41431-021-01015-4
work_keys_str_mv AT fordeclaire naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT burkittwrightemma naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT turnpennypeterd naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT haaneric naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT ealingjohn naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT mansoursahar naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT holdermuriel naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT lahirinayana naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT dixitabhijit naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT procterannie naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT pacotlaurence naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT vidauddominique naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT capriyline naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT gerardmarion naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT dollfushelene naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT schaeferelise naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT quelinchloe naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT sigaudysabine naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT busatiffany naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT veragabriella naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT damajlena naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT messiaenludwine naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT stevensondavida naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT daviespeter naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT palmersmithsheila naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT callawayalison naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT wolkensteinpierre naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT pasmanteric naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy
AT upadhyayameena naturalhistoryofnf1c29702972delpmet992delconfirmationofalowriskofcomplicationsinalongitudinalstudy